Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Is there any role for physical therapy in chronic GvHD?
Bone Marrow Transplant. 2018 Jan;53(1):22-28. doi: 10.1038/bmt.2017.155. Epub 2017 Aug 7.
Bone Marrow Transplant. 2018.
PMID: 28783145
Chronic GvHD is the leading cause of non-relapse mortality in recipients of hematopoietic cell transplantation. Although the benefit of physical therapy (PT) has been reported in some GvHD studies, a literature gap is identified in demonstrating the exact role of different …
Chronic GvHD is the leading cause of non-relapse mortality in recipients of hematopoietic cell transplantation. Although the benefit …
The Relationship Between Busulfan Exposure and Achievement of Sustained Donor Myeloid Chimerism in Patients with Non-Malignant Disorders.
Apsel Winger B, Shukla P, Kharbanda S, Keizer RJ, Goswami S, Cowan MJ, Dvorak CC, Long-Boyle J.
Apsel Winger B, et al.
Transplant Cell Ther. 2021 Mar;27(3):258.e1-258.e6. doi: 10.1016/j.jtct.2020.12.005. Epub 2020 Dec 16.
Transplant Cell Ther. 2021.
PMID: 33781528
Free article.
The overall objective of allogeneic hematopoietic cell transplantation (HCT) in patients with non-malignant conditions involves replacing a dysfunctional or absent cell or gene product for disease correction. ...Median busulfan cAUC for all patients was 70 mg.h/L (range, …
The overall objective of allogeneic hematopoietic cell transplantation (HCT) in patients with non-malignant conditions involves repla …
Item in Clipboard
Cite
Cite